Medivizor

Title of notification

Here comes the notification
X
 
icon
icon
rheumatoid arthritis | Research | Treatment | 2 pages | source: Nature reviews. Rheumatology | Added Nov 27, 2015

What is the drug of choice after the failure of a TNF-inhibitor

This review discusses the choice of second-line treatment when patients fail to respond to a first tumor necrosis factor (TNF)-inhibitor in rheumatoid arthritis.

icon
breast cancer | Clinical Trial | Added Nov 20, 2015

Searching for locally recurrent or metastatic breast cancer patients with BRCA mutation to test combination chemotherapy

This Phase 2 trial in multiple locations in the US aims to test the effectiveness of a combination of veliparib (ABT-888), temozolomide (Temodal), carboplatin (Cisplatin), and paclitaxel (Taxol) in subjects with BRCA1 and BRCA2 mutations and metastatic breast cancer. The main outcome is to examine whether various combinations of the drugs can extend survival in these patients.

icon
breast cancer | Clinical Trial | Added Nov 18, 2015

Looking for women breast cancer survivors with chronic pain to test meditation for pain relief

This interventional trial in Canada (Ottawa, Ontario) aims to evaluate the ability of mindfulness-based stress reduction in combination with medical treatment, to provide relief from painful nerve damage in breast cancer survivors. The main outcome to be measured is pain level after treatment.

icon
icon
rheumatoid arthritis | Research | Treatment | 12 pages | source: Annals of internal medicine | Added Nov 17, 2015

Effectiveness and harms of rheumatoid arthritis drugs

This review compared the benefits and safety of different rheumatoid arthritis drugs.

icon
breast cancer | Research | 9 pages | source: Cancer Treatment Reviews | Added Nov 15, 2015

Evaluating bone health in breast cancer patients

This review examines the role of bisphosphonates in postmenopausal (after menopause) women with breast cancer.

icon
rheumatoid arthritis | Clinical Trial | Added Nov 15, 2015

Looking for rheumatoid arthritis patients at Brigham and Women's Hospital

This study, recruiting in Boston, Massachusetts, will evaluate several parameters in rheumatoid arthritis (RA) patients based on observation. The primary outcomes to be investigated are the biomarkers that predict drug response and side effects in RA.

icon
icon
rheumatoid arthritis | Research | Treatment | 9 pages | source: Nature reviews. Rheumatology | Added Nov 12, 2015

Ocular complications associated with rheumatoid arthritis

This review covers common ocular complications (related to the eyes) associated with rheumatoid arthritis and provides an overview of available therapies.

icon
icon
breast cancer | Research | Treatment | 20 pages | source: The Lancet | Added Nov 06, 2015

Postoperative radiotherapy prevents breast cancer recurrence and prolongs survival

This study evaluated if strategies to prevent cancer recurrence are associated with prolonged survival 15 years after treatment. Their main findings were that postoperative radiation managed to prevent cancer recurrence and was associated with higher rates of long-term survival.

icon
icon
breast cancer | Research | Treatment | 12 pages | source: The Lancet | Added Nov 06, 2015

Benefits of 10-year versus 5-year Tamoxifen treatment

Tamoxifen treatment is given to many breast cancer patients after surgery to prevent recurrences and improve survival. It is usually given for a maximum of 5 years. This study determined that longer treatments offer further survival benefit.

icon
icon
rheumatoid arthritis | Research | Treatment | 7 pages | source: Annals of the rheumatic diseases | Added Nov 06, 2015

Long-term safety of rituximab in rheumatoid arthritis

This study evaluated the long-term safety of rituximab (Rituxan) in the treatment of rheumatoid arthritis.

View

Conditions

Category

  • icon
  • icon
  • icon
  • icon
  • icon
  • icon
  • icon
  • icon
  • icon

Was this helpful?